Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 21

1.

Tolerogenic Iron Oxide Nanoparticles in Type 1 Diabetes: Biodistribution and Pharmacokinetics Studies in Nonobese Diabetic Mice.

Dubreil C, Sainte Catherine O, Lalatonne Y, Journé C, Ou P, van Endert P, Motte L.

Small. 2018 Oct;14(40):e1802053. doi: 10.1002/smll.201802053. Epub 2018 Sep 5.

PMID:
30184337
2.

α-Halogenated oxaphosphinanes: Synthesis, unexpected reactions and evaluation as inhibitors of cancer cell proliferation.

Babouri R, Rolland M, Sainte-Catherine O, Kabouche Z, Lecouvey M, Bakalara N, Volle JN, Virieux D, Pirat JL.

Eur J Med Chem. 2015 Nov 2;104:33-41. doi: 10.1016/j.ejmech.2015.09.027. Epub 2015 Sep 28.

PMID:
26433617
3.

C-glycoside mimetics inhibit glioma stem cell proliferation, migration, and invasion.

Clarion L, Jacquard C, Sainte-Catherine O, Decoux M, Loiseau S, Rolland M, Lecouvey M, Hugnot JP, Volle JN, Virieux D, Pirat JL, Bakalara N.

J Med Chem. 2014 Oct 23;57(20):8293-306. doi: 10.1021/jm500522y. Epub 2014 Oct 10.

PMID:
25211466
4.

Bisphosphonate prodrugs: synthesis and biological evaluation in HuH7 hepatocarcinoma cells.

Monteil M, Migianu-Griffoni E, Sainte-Catherine O, Di Benedetto M, Lecouvey M.

Eur J Med Chem. 2014 Apr 22;77:56-64. doi: 10.1016/j.ejmech.2014.02.054. Epub 2014 Feb 23.

PMID:
24607589
5.

Synthesis and biological evaluation of new bisphosphonate-dextran conjugates targeting breast primary tumor.

Migianu-Griffoni E, Chebbi I, Kachbi S, Monteil M, Sainte-Catherine O, Chaubet F, Oudar O, Lecouvey M.

Bioconjug Chem. 2014 Feb 19;25(2):224-30. doi: 10.1021/bc400317h. Epub 2014 Jan 22.

PMID:
24400882
6.

Oxaphosphinanes: new therapeutic perspectives for glioblastoma.

Clarion L, Jacquard C, Sainte-Catherine O, Loiseau S, Filippini D, Hirlemann MH, Volle JN, Virieux D, Lecouvey M, Pirat JL, Bakalara N.

J Med Chem. 2012 Mar 8;55(5):2196-211. doi: 10.1021/jm201428a. Epub 2012 Feb 14.

PMID:
22268526
7.

Invading basement membrane matrix is sufficient for MDA-MB-231 breast cancer cells to develop a stable in vivo metastatic phenotype.

Abdelkarim M, Vintonenko N, Starzec A, Robles A, Aubert J, Martin ML, Mourah S, Podgorniak MP, Rodrigues-Ferreira S, Nahmias C, Couraud PO, Doliger C, Sainte-Catherine O, Peyri N, Chen L, Mariau J, Etienne M, Perret GY, Crepin M, Poyet JL, Khatib AM, Di Benedetto M.

PLoS One. 2011;6(8):e23334. doi: 10.1371/journal.pone.0023334. Epub 2011 Aug 15.

8.

Superparamagnetic bifunctional bisphosphonates nanoparticles: a potential MRI contrast agent for osteoporosis therapy and diagnostic.

Lalatonne Y, Monteil M, Jouni H, Serfaty JM, Sainte-Catherine O, Lièvre N, Kusmia S, Weinmann P, Lecouvey M, Motte L.

J Osteoporos. 2010 Jun 15;2010:747852. doi: 10.4061/2010/747852.

9.

Structural characterization and cytotoxic properties of an apiose-rich pectic polysaccharide obtained from the cell wall of the marine phanerogam Zostera marina.

Gloaguen V, Brudieux V, Closs B, Barbat A, Krausz P, Sainte-Catherine O, Kraemer M, Maes E, Guerardel Y.

J Nat Prod. 2010 Jun 25;73(6):1087-92. doi: 10.1021/np100092c.

PMID:
20465284
10.

In vitro assessment of liposomal neridronate on MDA-MB-231 human breast cancer cells.

Chebbi I, Migianu-Griffoni E, Sainte-Catherine O, Lecouvey M, Seksek O.

Int J Pharm. 2010 Jan 4;383(1-2):116-22. doi: 10.1016/j.ijpharm.2009.09.011. Epub 2009 Sep 11.

PMID:
19748562
11.

Superparamagnetic nanovector with anti-cancer properties: gamma Fe2O3@Zoledronate.

Benyettou F, Lalatonne Y, Sainte-Catherine O, Monteil M, Motte L.

Int J Pharm. 2009 Sep 11;379(2):324-7. doi: 10.1016/j.ijpharm.2009.04.010. Epub 2009 Apr 15.

PMID:
19457625
12.

New symmetrically esterified m-bromobenzyl non-aminobisphosphonates inhibited breast cancer growth and metastases.

Abdelkarim M, Guenin E, Sainte-Catherine O, Vintonenko N, Peyri N, Perret GY, Crepin M, Khatib AM, Lecouvey M, Di Benedetto M.

PLoS One. 2009;4(3):e4685. doi: 10.1371/journal.pone.0004685. Epub 2009 Mar 5.

13.

Structural characterization and cytotoxic properties of a 4-O-methylglucuronoxylan from castanea sativa. 2. Evidence of a structure-activity relationship.

Barbat A, Gloaguen V, Moine C, Sainte-Catherine O, Kraemer M, Rogniaux H, Ropartz D, Krausz P.

J Nat Prod. 2008 Aug;71(8):1404-9. doi: 10.1021/np800207g. Epub 2008 Jul 23.

PMID:
18646856
14.

Synthesis and biological activity of mustard derivatives of thymine.

Hadj-Bouazza A, Teste K, Colombeau L, Chaleix V, Zerrouki R, Kraemer M, Sainte Catherine O.

Nucleosides Nucleotides Nucleic Acids. 2008 May;27(5):439-48. doi: 10.1080/15257770802086872.

PMID:
18569783
15.

Glycosaminoglycans and their synthetic mimetics inhibit RANTES-induced migration and invasion of human hepatoma cells.

Sutton A, Friand V, Papy-Garcia D, Dagouassat M, Martin L, Vassy R, Haddad O, Sainte-Catherine O, Kraemer M, Saffar L, Perret GY, Courty J, Gattegno L, Charnaux N.

Mol Cancer Ther. 2007 Nov;6(11):2948-58.

16.

Vascular endothelial growth factor-C and its receptor VEGFR-3 in non-small-cell lung cancer: concurrent expression in cancer cells from primary tumour and metastatic lymph node.

Saintigny P, Kambouchner M, Ly M, Gomes N, Sainte-Catherine O, Vassy R, Czernichow S, Letoumelin P, Breau JL, Bernaudin JF, Kraemer M.

Lung Cancer. 2007 Nov;58(2):205-13. Epub 2007 Aug 7.

PMID:
17686546
17.

Stromal cell-derived factor-1/chemokine (C-X-C motif) ligand 12 stimulates human hepatoma cell growth, migration, and invasion.

Sutton A, Friand V, Brulé-Donneger S, Chaigneau T, Ziol M, Sainte-Catherine O, Poiré A, Saffar L, Kraemer M, Vassy J, Nahon P, Salzmann JL, Gattegno L, Charnaux N.

Mol Cancer Res. 2007 Jan;5(1):21-33.

18.

Structural characterization and cytotoxic properties of a 4-O-methylglucuronoxylan from Castanea sativa.

Moine C, Krausz P, Chaleix V, Sainte-Catherine O, Kraemer M, Gloaguen V.

J Nat Prod. 2007 Jan;70(1):60-6.

PMID:
17253851
19.

A new dimethyl ester bisphosphonate inhibits angiogenesis and growth of human epidermoid carcinoma xenograft in nude mice.

Ledoux D, Hamma-Kourbali Y, Di Benedetto M, Foucault-Bertaud A, Oudar O, Sainte-Catherine O, Lecouvey M, Kraemer M.

Anticancer Drugs. 2006 Apr;17(4):479-85.

PMID:
16550007
20.

Growth inhibition of MCF-7 tumor cell line by phenylacetate linked to functionalized dextran.

Frank L, Avramoglou T, Sainte-Catherine O, Jozefonvicz J, Kraemer M.

J Biomater Sci Polym Ed. 2004;15(10):1305-15.

PMID:
15559851
21.

Sodium phenylacetate modulates the synthesis of autocrine and paracrine growth factors secreted by breast cancer cell lines.

Thibout D, Di Benedetto M, Kraemer M, Sainte-Catherine O, Derbin C, Crépin M.

Anticancer Res. 1998 Jul-Aug;18(4A):2657-61.

PMID:
9703924

Supplemental Content

Loading ...
Support Center